Results

Total Results: 1,528 records

Showing results for "drugs".

321. Treatment for Restless Legs Syndrome: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
     February 01, 2013 - What is the effectiveness of approved RLS drugs on patient subgroups such as children, older adults … O 2 What is the effectiveness of other drugs that are not dopamine agonists or alpha 2 ligands (e.g. … Comparator Nontreatment, drugs, or nondrug therapies. … Nontreatment, drugs, or nondrug therapies. … • What is the effectiveness of other drugs that are not dopamine agonists or alpha 2 ligands (e.g.

322. Improving Medication Safety in High Risk Medicare Beneficiaries Toolkit (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research.pdf
     July 01, 2012 - In isolation, identifying specific drugs to avoid is not sufficient for improving safety. … Drugs 2009;69(4):393-406. 21. Touchette DR, Burns AL, Bough MA, et al. … Different brand name drugs have different Orange Book AB ratings, and generics vary in their combination … If so, with what drugs and what was the reaction? 2. What is your height? 3. … C4.6 C4.7 C4.8 C4.9 C4.10 Patient forgets to use/take drug Patient has concerns with drugs

323. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
     October 01, 2009 - comorbidities (diabetes, renal dysfunction, hypertension), and other medications (vitamins, lipid lowering drugs … research is needed to determine if ACE inhibitors or ARBs offer additional benefits over other vasoactive drugs … Since ONTARGET directly compared the same drugs as were evaluated in the placebo-controlled HOPE and … We cannot determine the comparative benefits and harms associated with the use of these drugs in these … disease and preserved left ventricular function is superior or inferior to adding other cardiovascular drugs

324. AHRQ Evidence-based Practice Center Program Research Gaps Summary: Primary Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
     March 01, 2022 - Messages • Compared with placebo, treatments such as triptans, NSAIDs (nonsteroidal anti-inflammatory drugs … Some opioids may be less effective than other drugs. … Key Messages • Opioids are probably less effective than nonsteroidal anti-inflammatory drugs (NSAIDs … neuropathy/post-herpetic neuralgia and fibromyalgia, and small with nonsteroidal anti- inflammatory drugs … on treatments for acute pain including nondrug interventions, multicomponent interventions, and drugs

325. Comparative Effectiveness and Safety of New Therapies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
     July 01, 2010 - Exenatide, manufactured as Byetta by Amylin Pharmaceuticals, Inc. … Additionally, a separate, linkable file is available which includes pharmacy claims for prescription drugs … In Table 3, we provide details about the other drugs for DM used by these patients. … Experts weigh in on promotion, prescription of off-label drugs. JAMA 2007;297:683-684. 15.

326. Methods Guide for Medical Test Reviews Chapter 4 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-search_methods.pdf
     July 01, 2012 - issues, including community health EMBASE http://www.embase.com Biomedical, with and emphases on drugs … and pharmaceuticals, more non-U.S. coverage than MEDLINE EMCare http://www.elsevier.com/wps/find … instruments IPA (international Pharmaceutical Abstracts) http://www.csa.com/factsheets/ipa-set-c.php Drugs … and pharmaceuticals MANTIS (Manual Alternative and Natural Therapy Index System) http://www.healthindex.com

327. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
     February 01, 2012 - For the majority of antipsychotic drugs, approved indications in the United States are restricted to … We reviewed FDA documents related to the eligible drugs to identify additional data. … Because patients in clinical practice often have multiple diagnoses and undergo cotreatment with several drugs … term outcomes, most of the evidence examining head- to-head comparisons of different antipsychotic drugs

328. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypothyroidism-hyperthyroidism-screening-treatment_research-protocol.pdf
     March 11, 2010 - disease, family history of thyroid disease, atrial fibrillation, and ingestion of iodine-containing drugs … Treatment of hyperthyroidism includes antithyroid drugs and radioactive iodine treatment. … Name: Levothyroxine sodium (Brand Name: Levo-T, Synthroid, Levothroid, Levoxyl, Unithroid); All drugs … Antithyroid Drugs: a. Mild temporary fever b. Hives, skin rash, itching, allergic reaction c.

329. S166 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s166.pdf
     October 01, 2007 - ORIGINAL ARTICLE Comparison of Meta-Analytic Results of Indirect, Direct, and Combined Comparisons of Drugs … advantage for NBNZ (with Medical Care • Volume 45, Number 10 Suppl 2, October 2007 Comparisons of Drugs … effect threshold has been Medical Care • Volume 45, Number 10 Suppl 2, October 2007 Comparisons of Drugs … Medical Care • Volume 45, Number 10 Suppl 2, October 2007 Comparisons of Drugs for Chronic Insomnia

330. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-provider-adherence_research-protocol.pdf
     March 02, 2012 - use of short-acting B2 agonists, parental/patient perceptions/ratings of care, and side effects of drugs … of short-acting B2 agonists  Parental/patient perceptions/ratings of care  Side effects of drugs … rescue use of short-acting B2 agonists, parental/patient perceptions/ratings of care, side effects of drugs … use of short-acting B2 agonists  Parental/patient perceptions/ratings of care  Side effects of drugs

331. Slide 1 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/marketing_evidence_evans.ppt
     September 13, 2006 - evidence” to healthcare consumers: Applying social marketing to evidence about the harms and benefits of pharmaceuticals … Agency for Healthcare Research and Quality Conference: Communicating Harms and Benefits of Prescription Drugs … information to counter the effects of marketing by companies with competing interests (e.g., tobacco, pharmaceuticals … promotion tool Evidence-based AED Dissemination Model Potential Lessons for Health Care Pharmaceuticals … Agency for Healthcare Research and Quality Conference: Communicating Harms and Benefits of Prescription Drugs

332. Disposition of Comments Report for Treatment for Hepatitis C Virus Infection in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_disposition-comments.pdf
     November 27, 2012 - However, with new drugs such as the protease inhibitors, it is also important to understand the results … On Page 3, Table 1 describes the pharmacokinetics, indications and dosing of included drugs. … The dosing recommendations are included for all drugs except for boceprevir. … The Table is intended to describe the pharmacokinetics, indications, and dosing of included drugs, … Page 69: "… specific harms associated with use of these drugs (such as hematologic adverse events with

333. Effectiveness of Treatments for Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
     May 09, 2016 - fulranumab, the protein kinase C-beta inhibitor ruboxistaurin, gangliosides, and prostaglandin E1.7 These drugs … These include drugs with direct impact on neurotransmitters and inhibitory pathways or binding to opioid … Since this review and guideline was completed, new trials have been conducted on the drugs evaluated … Parallel or crossover randomized controlled trials, at least 10 patients (for studies of drugs, and … Belge Lamictal (Lamotrigine) GlaxoSmithKline Trileptal (Oxcarbazepine) Novartis Topiramate Mylan Pharmaceuticals

334. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
     March 01, 2011 - In 1995, the only drugs for treating type 2 diabetes were sulfonylureas and insulin. … studies concluded that most oral diabetes medications had a similar effect on reducing HbA1c, most drugs … associated with weight gain, with a mean difference of about −2.6 kg between metformin and the other drugs … We focused primarily on the relative differences between drugs in our analyses. … This is a shorter duration of exposure than is typically seen in clinical practice, in which these drugs

335. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease_research-protocol.pdf
     September 01, 2010 - which can include increased risk for infection as well as lymphoma) and the costs associated with the drugs … Most of the immunosuppressive drugs used for this disease have the potential for rare but significant … These drugs are associated with reductions in surgeries and hospitalizations and improved mucosal healing … 2010 AND (agent*[tiab] OR treatment*[tiab] OR treated[tiab] OR therap*[tiab] OR drug[tiab] OR drugs … List of Disease-Modifying Drugs Class Generic name US trade name Route Half-life Mechanism of Action

336. Comparative Effectiveness of Second Generation Antidepressants in the Pharmacologic Treatment of Adult Depression—An Update to a 2007 Report. (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_disposition-comments.pdf
     December 01, 2011 - would be drug vs drug and class vs class, and a separate one for comparing long and short-acting drugs … Hopefully not influenced by drug company marketing efforts to differentiate their drugs! … Basically, there are few differences between SGA drugs in the treatment of depression. … other second-generation antidepressants (Table 15)—and then listed alphabetically by the specific drugs … Section citalopram versus escitalopram (page 17, manuscript page 3): Although a difference between drugs

337. Comparative Effectiveness and Safety of Analgesics for Osteoarthritis—An Update of the 2006 Report. (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-disposition-120516.pdf
     October 01, 2011 - Kathleen Gans- Brangs, PhD Executive Summary AstraZeneca (encompassing AstraZeneca Pharmaceuticals … AstraZeneca is committed to the discovery of drugs that will allow patients to lead longer, healthier … effectiveness and safety of analgesics for osteoarthritis" represents an excellent summary of the drugs … I appreciated the overview of the pharmaceuticals reviewed including both the risk and benefits of … These drugs have very dose dependent toxicity, and that issue is completely unexplored.

338. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Drugs. 2011 Dec 24;71(18):2381-9. PMID: 22117130 7. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Dec [accessed 2013 Jun 5]. [19 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 May 12 [accessed 2011 Jul 15]. [2 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 Oct 31 [accessed 2011 Nov 11]. [4 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Oct 16 [accessed 2012 Oct 16]. [3 p].

339. high-cholesterol-medicines-update-protocol-130516 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
     December 31, 2013 - approved only for treatment of homozygous FH – mipomersen and lomitapide • Drugs not approved by … FDA, as well as the scientific information packets provided by pharmaceutical manufacturers of all drugs … provided in the Scientific Information Package provided by the AHRQ Scientific Resource Center on the drugs … • Intervention We will include drugs that were not previously FDA-approved at the time of the previous … Drugs that will potentially be approved by the FDA in the near future will be included, specifically

340. Maternal and Fetal Effects of Mental Health Treatments in Pregnant and Breastfeeding Women: A Systematic Review of Pharmacological Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/protocol-pharm-pregnant-women_0.pdf
     December 05, 2018 - The likelihood of perinatal exposure to psychotropic drugs is high and increasing. … increased from 1.57 percent of deliveries to 2.19 percent.20 Currently no drugs target postpartum depression … † Drugs such as brexanolone that are awaiting FDA approval will be included in the review in the review … Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure … * OR "antidepressive agent" OR "antidepressive agents" OR "antidepressive drug" OR "antidepressive drugs